Category: Zacks Small Cap Research
By Steven Ralston, CFATSX:WML.VOTC:WMLLFREAD THE FULL RESEARCH REPORT HEREWealth Minerals (TSX:WML.V) (OTC:WMLLF) is a junior mineral exploration company that is well-positioned to benefit from its portfolio of prospective lithium projects in the Lit ...
By David Bautz, PhDREAD THE FULL RESEARCH REPORT HERE NASDAQ:SNGXBusiness UpdateInnate Defense Regulators Offer Novel Means to Treat InfectionsSoligenix, Inc. (NASDAQ:SNGX) recently published a review of the potential clinical applications for innate ...
By David Bautz, PhDNASDAQ:AGRXREAD THE FULL RESEARCH REPORT HEREBusiness UpdateAdhesion Study SuccessfulOn February 11, 2019, Agile Therapeutics, Inc. (NASDAQ:AGRX) announced positive topline results for the comparative adhesion study that tested the ...
By Steven Ralston, CFANASDAQ:DSKEREAD THE FULL DSKE RESEARCH REPORTEXECUTIVE SUMMARY OF RECENT EVENTS‣ On February 7th, Daseke (NASDAQ:DSKE) preannounced select financial results for the fourth quarter and year ending December 31, 2018 and management ...
By John Vandermosten, CFANASDAQ:TTNPWe have now had more than two full quarters of in-house management of Probuphine commercialization by Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) and indications are that shipment trends are strong. Since the company ...
By Steven Ralston, CFAOTC:PQEFF | TSX:PQEREAD THE FULL PQEFF RESEARCH REPORTPetroteq Energy (OTC:PQEFF) (TSX:PQE) is an upstream exploration and production (E&P) company focused on advancing its proprietary Clean Oil Recovery Technology (CORT). C ...
By John Vandermosten, CFANYSE:CVMREAD THE FULL CVM RESEARCH REPORTWe are initiating coverage of CEL-SCI Corporation (NYSE:CVM) with a $14.00 price target based on our estimates for a 2021 US and 2022 EU launch of lead compound Multikine in squamous c ...
By Steven Ralston, CFANASDAQ:MNGAREAD THE FULL MNGA RESEARCH REPORTMagneGas (NASDAQ:MNGA) / Taronis Technologies produces, sells and distributes a clean, hydrogen-based fuel synthesized through its proprietary, patented Plasma Arc Flow™ process. Curr ...
By Lisa ThompsonNASDAQ:OIIMREAD THE FULL OIIM RESEARCH REPORTO2Micro (NASDAQ:OIIM) reported Q4 2018 revenues of $16.6 million, down slightly sequentially, but still up 9.0% year over year and within the range of guidance. Guidance for revenue for the ...
By David Bautz, PhDNYSE:OGENREAD THE FULL OGEN RESEARCH REPORTBusiness UpdateNew Publication of Preclinical Data for OG716 On January 28, 2019, Oragenics, Inc. (NYSE:OGEN) announced the publication of new preclinical data for the company’s lead lanti ...